Corpus Intelligence IC Memo — DUNDY COUNTY HOSPITAL 2026-04-27 00:13 UTC
IC Memo — DUNDY COUNTY HOSPITAL
Investment Committee Memorandum | NE | 12 beds | Grade D | EBITDA uplift $724K
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 281340

DUNDY COUNTY HOSPITAL

LOCATIONDUNDY, NE·BEDS12·AS OFApril 27, 2026
D
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

DUNDY COUNTY HOSPITAL is a 12-bed rural/critical access in DUNDY, NE with $9.7M in net patient revenue and a -35.7% operating margin. The hospital serves a payer mix of 83.2% Medicare, 3.0% Medicaid, and 13.8% commercial.

Thesis: Turnaround. Our ML models identify $724K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -35.7% to -28.2% (+742bps).

Net Revenue HCRIS$9.7M
Current EBITDA COMPUTED$-3.5M
Operating Margin COMPUTED-35.7%
Occupancy HCRIS15.7%
Revenue / Bed COMPUTED$812K
Net-to-Gross HCRIS72.3%
Distress Probability ML62.9%

2. Market Context & Competitive Position

98
NE Hospitals
-6.3%
State Median Margin
53
Comparable Hospitals

NE has 98 Medicare-certified hospitals with a median operating margin of -6.3%. The target's margin of -35.7% places it below the state median. Among 53 size-comparable peers (6-24 beds), the median margin is -7.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (6-24), prioritizing same-state peers. 53 hospitals in the comp set.

HospitalStateBedsRevenueMargin
DUNDY COUNTY HOSPITAL (Target)NE12$9.7M-35.7%
NEBRASKA ORTHOPAEDIC HOSPITAL NE24$112.1M22.5%
LINCOLN SURGICAL HOSPITALNE20$80.9M18.8%
MIDWEST SURGICAL HOSPITALNE19$70.1M36.2%
SIDNEY REGIONAL MEDICAL CENTERNE19$68.0M0.8%
MEMORIAL COMMUNITY HOSPITALNE21$44.8M1.2%
MEMORIAL HEALTH CARE SYSTEMSNE24$42.0M4.4%
SAINT MARYS HOSPITALNE18$39.5M3.4%
SAUNDERS COUNTY HEALTH SERVICENE16$35.9M-0.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $724K (742bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$205K+210bp18mo
Denial Rate Reduction12.0%6.5%$196K+201bp12mo
Cost to Collect4.5%2.5%$195K+200bp12mo
A/R Days Reduction5200.0%3800.0%$119K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+10bp6mo

5. EBITDA Bridge

Net Collection Rate
$205K
Denial Rate Reduction
$196K
Cost to Collect
$195K
A/R Days Reduction
$119K
Clean Claim Rate
$10K
Total EBITDA Uplift$724K
Current EBITDA$-3.5M
+ RCM Uplift+$724K
Pro Forma EBITDA$-2.8M
Current Margin-35.7%
Pro Forma Margin-28.2%
WC Released (1x)$374K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-5.3M$-15.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-5.3M$-19.0M0.00x-100.0%
Bull Case9.0x11.0x$-4.8M$-18.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-4.8M$-21.4M0.00x-100.0%
Bear Case11.0x10.0x$-5.9M$-17.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-5.9M$-21.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 83.2% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 15.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 62.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 53 hospitals with 6-24 beds
  • Same-state prioritization (n=54)
  • Comp margins: P25=-13.3% / P50=-7.1% / P75=-0.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.